Sarjan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 59.40%
- Ebitda 59.40%
- Net Worth -6.26%
- Total Assets -1.49%
About Sarjan Pharmaceuticals
Sarjan Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2017 (Seven years and 11 months 14 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jerambhai Sheladia, Kalubhai Malani, Sanjay Gaudani, and Five other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304GJ2017PTC095830
-
Company No.
095830
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sarjan Pharmaceuticals?
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gaudani
|
Director | 16-Feb-2017 | Current |
|
Rakesh Lukhi
|
Director | 06-Mar-2017 | Current |
|
Maulikumar Butani
|
Director | 06-Mar-2017 | Current |
|
Kapilkumar Bhimani
|
Director | 06-Mar-2017 | Current |
|
Jerambhai Sheladia
|
Director | 16-Feb-2017 | Current |
|
Kalubhai Malani
|
Director | 16-Feb-2017 | Current |
Financial Performance of Sarjan Pharmaceuticals.
Sarjan Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 59.4% increase in profit. The company's net worth dipped by a decrease of 6.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarjan Pharmaceuticals?
In 2022, Sarjan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sarjan Construction Private LimitedJerambhai Sheladia, Kalubhai Malani and 2 more are mutual person
-
Leo Nutriscience LlpJerambhai Sheladia, Kalubhai Malani and 2 more are mutual person
-
Kmrs Pharma Private LimitedJerambhai Sheladia, Kalubhai Malani and 6 more are mutual person
-
Nirali Projects Private Limited
Sanjay Gaudani is a mutual person
-
Montec Square Limited
Sanjay Gaudani is a mutual person
-
Gdv Infrastructure Private Limited
Sanjay Gaudani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarjan Pharmaceuticals?
Unlock and access historical data on people associated with Sarjan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarjan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarjan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.